10,665 Shares in Humana Inc. (NYSE:HUM) Acquired by Cinctive Capital Management LP

Cinctive Capital Management LP bought a new position in Humana Inc. (NYSE:HUM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 10,665 shares of the insurance provider's stock, valued at approximately $2,706,000.

A number of other institutional investors have also bought and sold shares of the business. Transcend Capital Advisors LLC boosted its stake in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after acquiring an additional 2,914 shares during the period. FNY Investment Advisers LLC boosted its stake in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after purchasing an additional 26,856 shares during the period. Retirement Systems of Alabama grew its holdings in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after buying an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after buying an additional 65,735 shares during the last quarter. Finally, Secure Asset Management LLC purchased a new position in shares of Humana in the fourth quarter worth $244,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Trading Up 10.3 %

Shares of NYSE:HUM traded up $26.13 during trading on Tuesday, reaching $280.84. 2,164,951 shares of the company were exchanged, compared to its average volume of 1,725,707. The business's fifty day simple moving average is $266.73 and its 200-day simple moving average is $271.15. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The firm has a market capitalization of $33.89 billion, a PE ratio of 28.30, a P/E/G ratio of 2.05 and a beta of 0.62.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.26%. The ex-dividend date is Friday, March 28th. Humana's payout ratio is 35.58%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on HUM. JPMorgan Chase & Co. reduced their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Piper Sandler lifted their target price on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Barclays raised their price target on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Finally, Truist Financial raised their target price on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Seventeen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $280.17.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.